Navigation Links
KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission
Date:6/25/2008

Company Files Fiscal Form 10-Q's for First Three Quarters of Fiscal 2008

and Form 10-K for Fiscal 2008 Ended March 31, 2008

Points to Positive Fiscal 2009 Outlook for Its Branded and Generic

Pharmaceutical Businesses

ST. LOUIS, June 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology distinguished branded and generic/non-branded prescription pharmaceutical products, today announced that it has filed Form 10-Q's for the quarters ended June 30, 2007, September 30, 2007 and December 31, 2007, as well as a Form 10-K for its 2008 fiscal year ended March 31, 2008. The financial data included in these filings is consistent with previously reported preliminary financial results.

Marc S. Hermelin, Chairman of the Board and Chief Executive Officer stated, "With the filing of our fiscal 2008 financial reports, the Company is now up to date with its Securities and Exchange Commission filings. Fiscal 2008 was an extraordinary year for KV filled with many accomplishments by both our branded and generic businesses. Our Company continued to perform at record levels despite a difficult industry environment. We fully expect to continue our strong performance in fiscal 2009 and beyond as we execute on our branded and generic strategies and seek to capitalize on our valuable product pipeline."

Mr. Hermelin continued, "As previously reported, KV generated net revenue and net income increases of 36% and 52%, respectively, for fiscal 2008 compared to the prior year. In fiscal 2009 the Company expects to introduce 8-10 new products from Ther-Rx and ETHEX combined, which includes the anticipated approval of six ANDA's and one NDA. The anticipated new products, continued momentum from KV's generic Metoprolol Succinate Extended Release tablets, and expansion of the Company's branded women
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Only 5 percent of seniors have changed M...vings, better service and improved coverage among ...lment season nears , , Be...y 5 percent of seniors have changed their Medicare... (16 percent) report they are likely to or are con...
(Date:11/9/2009)... Nov. 9 HUYA Bioscience Internat...utical innovation, today announced a strategic par... Ocean University of China. The agreement is anoth...ablished with China,s leading research and develop...bal development and commercialization of novel bio...
(Date:11/9/2009)...l. -- Gifted young athletes are under increasing p... a new Loyola University Health System study of 51...lization increases the risk of injury. Researchers...s Association junior competition found that player...to withdraw from tournaments for medical reasons, ...
(Date:11/9/2009)...niversity study involving 2,453 women ages 18 to 6...alone or with a partner contributed to higher rati...al lubricants have long been recommended to women ...o reduce the risk of vaginal tearing, yet striking...se of lubricants or associated vaginal symptoms. ...
(Date:11/8/2009)..., Nov. 8 Jon O,Brien, p...wing statement about the passage of HR 3962: ,...can voters a lot about core values. We in the proc...eking to overcome the struggles ordinary Americans...many cannot afford basic healthcare or have to cho...
Breaking Medicine News(10 mins):Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 2Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 3Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 4Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 5Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3Health News:Catholics for Choice Statement on Healthcare Reform Bill 2
...ash., March 30 Becoming the first long term care ...ee owned, Evergreen Healthcare and its affiliates ... from private ownership to being 100% owned by an ...ll have long, fulfilling careers with Evergreen He...
... CRME TSX: COM, , , VANCOUVER, March 30 /PRNews...RME / TSX: COM) today reported financial results f...ss specified otherwise, are expressed in Canadian ...nge rate was CAD$1.00=US$0.8210. , , Summary Fisc...
...Y, Pa., March 30 Air Products (NYSE: APD ) has ...manager, Global Liquid Bulk, Generated Gases, and ...ble for the worldwide leadership and management of...iness Services, where he led the company,s efforts...
... cells and the chemicals used to make bombs can fo...too small for conventional detection techniques. T...tion: a molecule that can magnify weak traces of "...rly Sackler School of Chemistry has engineered new...
...rch 30 A new study released today by the national...mocracy finds that medical devices for the heart h...hs, yet patients currently have no legal recourse ..., comes one day before dozens of patients living w...
..., March 30 , , (Logo: http://www.newscom.com/... David Gulian, President and CEO of InfoLogix; Ric...; and Gerry Bartley, Executive Vice President and ...views. , , Topics of expertise include: , , , ...
Other Medicine News:Health News:Evergreen Healthcare L.L.C. Announces 100% Employee Ownership 2Health News:Cardiome Reports 2008 Results 2Health News:Cardiome Reports 2008 Results 3Health News:Cardiome Reports 2008 Results 4Health News:Air Products Appoints John Marsland VP and GM of Global Liquid Bulk, Generated Gases, and Helium 2Health News:A 'bionic nose' that knows 2Health News:Consumer Group Releases New Study About Defective Heart Devices and Implants; Patients Arrive in DC Tomorrow 2Health News:Healthcare IT Leaders from InfoLogix Address Gaps in EMR Implementation, Medical Error Reduction and Healthcare Cost Savings at HIMSS09 2
(Date:11/6/2009)...IS, Nov. 6 Recession in ...press sales for Allied Healthcare Products in the ... 30, 2009. ,, Sales declines pushed Allied into...rter was about $745,000, or negative 9 cents per s... about $208,000, or 3 cents per share. ,, Sale...
(Date:11/6/2009)..., Calif., Nov. 6 Kaiser Foundation...FHP/H), and their subsidiaries reported today a co...r the quarter ended September 30, 2009, compared t... Operating income in the third quarter was $336 mi...er of last year. Net non-operating income was $233...
(Date:11/6/2009)...TON, Nov. 6 America,s S...orking group of mid-market and smaller innovator p...about H.R. 3962, the "Affordable Health Care for A...ursday. These smaller companies fear that the cum...2 will hinder their efforts to bring new medicines...
Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 5106 1Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 5106 2 2416 8 million grant awarded to develop platelet recovery treatments 58550 1 2416 8 million grant awarded to develop platelet recovery treatments 58550 2Places to play but stranger danger fears keep inner city kids home 3A Study 58546 1
...efficient capture of lifestyle, demographics and c...t-in time saving and error checking devices such a... user definable pop up tables ensuring consistent ...n the pop up tables means that the user simply has...
RLISYS
K-4500
SF-3000
Medicine Products: